Laura G. Eichorn
Founder chez IMAGO BIOSCIENCES, INC.
Postes actifs de Laura G. Eichorn
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IMAGO BIOSCIENCES, INC. | Founder | 01/03/2012 | - |
| Director of Finance/CFO | - | - | |
| Chief Operating Officer | - | 24/03/2022 |
Historique de carrière de Laura G. Eichorn
Anciens postes connus de Laura G. Eichorn
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
FerroKin BioSciences, Inc.
 FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology FerroKin BioSciences, Inc. offers clinical stage biotechnology services for iron chelator in the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemia. The company was founded by Hugh Young Rienhoff, Jr. in 2007 and is headquartered in San Carlos, CA. | Chief Operating Officer | 01/01/2007 | - |
| Director of Finance/CFO | 01/01/2007 | - | |
| Corporate Officer/Principal | - | - |
Formation de Laura G. Eichorn
| Frostburg State University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Chief Operating Officer | 2 |
| Director of Finance/CFO | 2 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
FerroKin BioSciences, Inc.
FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology FerroKin BioSciences, Inc. offers clinical stage biotechnology services for iron chelator in the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemia. The company was founded by Hugh Young Rienhoff, Jr. in 2007 and is headquartered in San Carlos, CA. | Health Technology |
Imago BioSciences, Inc.
 Imago BioSciences, Inc. BiotechnologyHealth Technology Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops novel anti-cancer therapeutics. It translates science of genetics and epigenetics enzymes into novel medicines for treating myeloid diseases that pose challenges to patients, families, and physicians. The company also translates insights into transformative therapies that alter the history of disease allowing patients to live longer and disease-free lives. Imago BioSciences was founded by Hugh Young Rienhoff, Jr., Laura G. Eichorn and Jennifer Peppe on March 29, 2012 and is headquartered in Redwood City, CA. | Health Technology |
- Bourse
- Insiders
- Laura G. Eichorn
- Expérience
